2. The first "French group consensus" was published in 2018, advocating a better implementation of combination of HI #statins and #ezetimibe, as #PCSK9i weren't on the French market https://t.co/CjAovXnnca
RT @SABOURETCardio: @Hragy @DrMarthaGulati Just FYI. Few months before , the “French group” also was innovative to reach targets (we alread…
RT @SABOURETCardio: @Hragy @DrMarthaGulati Just FYI. Few months before , the “French group” also was innovative to reach targets (we alread…
@Hragy @DrMarthaGulati Just FYI. Few months before , the “French group” also was innovative to reach targets (we already considered 55 mg/dL even if #PCSK9i weren’t available in 🇫🇷). https://t.co/0Tsy7ThNS4
The link https://t.co/0Tsy7ThNS4
@SABOURETCardio @society_eas @ProfKausikRay @maciejbanach @DocSavageTJU @MeralKayikcoglu @MaasAngela Option 2 as previously proposed https://t.co/iqiYcuxen6
RT @AngoulvantD: @SABOURETCardio @DavidWienerMD @drshafikuchay Just as proposed in our 2016 publication "A consensus statement on lipid man…
@SABOURETCardio @DavidWienerMD @drshafikuchay Just as proposed in our 2016 publication "A consensus statement on lipid management after ACS" https://t.co/tdZxF93fus
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
More damage to the use of PCSK9 inhibitors. There is no clinical reason to continue to pigeon hole these breakthrough medications to patients with LDL > 130 mg/dL. Doing a disservice to our patients. Seriously?
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
RT @krychtiukmd: Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 a…
Challenging consensus statement on #lipid management after ACS published in @ESC_Journals Acute Cardiac Care! LDL > 100 after ACS - prescribe high intensity statin + ezetemibe say the authors! #Cardiology #ACS #Cardiotwitter #LDL #Cholesterol https: